China NMPA Product Recall - Surgical navigation system; neurosurgical navigation system

Medtronic (Shanghai) Management Co., Ltd. initiated a voluntary Class I recall of its surgical navigation systems and neurosurgical surgical navigation systems, specifically impacting the StealthStation system's Cranial software. This action, reported on December 8, 2021, through the National Medical Products Administration (NMPA) and Shanghai Municipal Drug Administration, addresses a critical software anomaly. The primary issue involves an abnormality in the biopsy depth guide bar display during cranial biopsy surgery navigation. This defect causes the software to desynchronize the biopsy depth guide bar with the real-time navigation information shown on the screen, resulting in an inaccurate display of the biopsy needle's position. Such an error could potentially lead to serious patient harm during medical procedures, necessitating the highest level of recall classification. Medtronic's proactive recall aims to mitigate risks associated with these affected devices, which include specific models under Registration Certificate Nos.: 20163012291 and 20173546129. The company has provided detailed information on affected product models, specifications, and batches in an accompanying "Medical Device Recall Event Report Form." This recall underscores the importance of maintaining precise software functionality in critical medical devices to ensure patient safety and the accuracy of surgical procedures.